Nazila Shafagati, MD

Title(s)Assistant Professor, Medicine
SchoolSchool of Medicine
Address654 Minnesota Street
San Francisco CA 94107
vCardDownload vCard

    Collapse Bibliographic 
    Collapse publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Characterizing Real-World Cutaneous Toxicity of Pegylated Liposomal Doxorubicin Across Multiple Malignancies. J Am Acad Dermatol. 2026 Nov 05. Bui T, Shafagati N, Song B, Blackford AL, Pierog O, Slavinsky V, Abreu D, Jedrych J, Satoskar S, Sandeep Kaduluri VP, Meyer C, Wagner-Johnston N, Ambinder R, Rozati S, Sterling C. PMID: 42988120.
      View in: PubMed   Mentions:
    2. Digital Biomarkers of Cytokine Release Syndrome: Scoping Review and Ontology Development of the Role and Relevance of Digital Measures Using a Mixed Methods Approach. J Med Internet Res. 2025 Dec 11; 27:e71956. Medberry CJ, Angel CZ, Batavia AS, Bradley S, Camerlingo N, Chen M, Datoo M, Kamdar P, Koenig E, Kusters L, Marquez C, Nukala U, Pettinati M, Phillips R, Sanchez DP, Shafagati N, Siegelman J, Stewart M, Varga C, Vandendriessche B, Wilkes M, Wolff-Hughes DL, Zahavi D, Zorman S, McClenahan SJ. PMID: 41380014; PMCID: PMC12699293.
      View in: PubMed   Mentions:
    3. Loncastuximab in high-risk and heavily pretreated relapsed/refractory diffuse large B-cell lymphoma: a realworld analysis from 21 US centers. Haematologica. 2025 03 01; 110(3):706-714. Zelikson V, Gurumurthi A, Sawalha Y, Annunzio K, Saha A, Dong N, Qualls D, Amoozgar B, Kahl B, Baird J, Challa P, Huntington SF, Santos J, Bair S, Narkhede M, Li S, Frosch Z, Ho C, Smith SD, Winter A, Landsburg D, Furqan F, Hamadani M, Baird K, Romancik J, Alharthy H, Law J, Bojanini L, Advani R, Hu B, Johnson PC, Grover NS, Merril M, Crombie JL, Shafagati N, Sterling C, Nastoupil LJ, Epperla N, Ayers EC. PMID: 39540227; PMCID: PMC11873705.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    4. Antibody-Based Therapies for Peripheral T-Cell Lymphoma. Cancers (Basel). 2024 Oct 15; 16(20). Shafagati N, Paul S, Rozati S, Sterling CH. PMID: 39456582; PMCID: PMC11506347.
      View in: PubMed   Mentions:
    5. Comparative efficacy and tolerability of novel agents vs chemotherapy in relapsed and refractory T-cell lymphomas: a meta-analysis. Blood Adv. 2022 08 23; 6(16):4740-4762. Shafagati N, Koh MJ, Boussi L, Park HJ, Stuver R, Bain P, Foss FM, Shen C, Jain S. PMID: 35816645; PMCID: PMC9631658.
      View in: PubMed   Mentions:
    Nazila's Networks
    Concepts (23)
    Derived automatically from this person's publications.
    _
    Co-Authors (1)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _